Lantern Pharma
LTRN2.6300.75% ( -0.020 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Lantern Pharma(LTRN) predict that the EBIT is -3.405 M (+28.67%), Beat estimate;the EPS is -0.3 (+28.57%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B28.67%
-0.00B10.98%
+0.00B17.69%
EPSExceed expectations
-0.328.57%
-0.3614.29%
+0.060014.28%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf